partially supported by the National Natural Science Foundation of China(81070171,81241121);the Specialized Research Fund for the Doctoral Program of Higher Education of China(20111106110013);the Capital Special Foundation of Clinical Application Research(Z121107001012015);the Capital Health Development Fund(2011400302);the Beijing Natural Science Foundation(7131014)
Objective Very early-onset coronary artery disease (CAD) is a great challenge in cardiovascular medicine throughout the world, especially regarding its early diagnosis. This study explored whether circulating microR...
Supported by National Natural Science Foundation of China(No.81070171 and 81241121);Specialized Research Fund for the Doctoral Program of Higher Education of China(No.20111106110013);Fund of Capital Special Foundation of Clinical Application Research(No.Z121107001012015)
Objective:To investigate the short- and long-term effects of Xuezhikang(血脂康,XZK),an extract of Cholestin,on proprotein convertase subtilisin/kexin type 9(PCSK9) level.Methods:Thirty rats were randomly divided...
This work was partially supported by the National Science Foundation of China (NSFC, No. 81070171) awarded to Dr. Li Jianjun.
Background Several studies investigating the prognostic utility of interleukin-10 (IL-10) in patients with acute coronary syndrome (ACS) have provided conflicting findings.The aim of the study was to assess the ex...